Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Preprints

Date Submitted: Jun 6, 2025
Open Peer Review Period: Jun 6, 2025 - May 22, 2026
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Physician-Managed Distribution of Urological Catheters: A Path to Efficiency

  • Tom Hata; 
  • Louise Secordel; 
  • Jennifer Perloff

ABSTRACT

Background:

The growing trend of integrated healthcare services within physician groups has improved care delivery by enhancing convenience, efficiency, and care coordination. However, it has also raised concerns about financial incentives potentially driving overutilization.

Objective:

We examine the impact of distribution method (traditional third-party referral versus physician-managed via Rx Redefined technology platform) on the quantity of urinary catheters supplied to Medicare patients.

Methods:

We analyzed utilization patterns for urological catheters (HCPCS codes A4351, A4352, and A4353) using 2021 Medicare claims data. We identified 54 urology specialists in core metropolitan areas who were enrolled in the Rx Redefined platform throughout 2021 and compared their utilization patterns with unenrolled urologists in the same regions. For enrolled physicians, who managed approximately 40 percent of their prescriptions through the platform, we also compared utilization between physician-managed and third-party distribution methods.

Results:

For catheter services A4351 and A4352, when distribution was managed by third parties, we found no significant differences in utilization (i.e. units supplied) between enrolled and unenrolled physicians. However, physician-managed distribution through Rx Redefined resulted in significantly lower utilization compared to third-party vendor distribution by non-enrolled physicians (p < 0.001 for both codes). In paired analysis of enrolled physicians, direct management showed significantly lower utilization compared to third-party distribution for A4351 (p = 0.014), but this difference was not significant for A4352 (p = 0.62).

Conclusions:

These findings demonstrate that physician-managed catheter distribution does not lead to increased utilization. In fact, for certain catheter types, physician-managed distribution may result in lower utilization compared to traditional third-party referral methods, suggesting a potential reduction in oversupply and improved efficiency.


 Citation

Please cite as:

Hata T, Secordel L, Perloff J

Physician-Managed Distribution of Urological Catheters: A Path to Efficiency

JMIR Preprints. 06/06/2025:78670

DOI: 10.2196/preprints.78670

URL: https://preprints.jmir.org/preprint/78670

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.